Profil
Matthew R.
Kane is the founder of Precision BioSciences, Inc., founded in 2006, where the titles held included President, Chief Executive Officer & Director from 2006 to 2021.
The current job is Non-Executive Director at Celyad Oncology SA starting in 2024.
Former jobs include Chief Executive Officer & Director at Tune Therapeutics, Inc. and Principal at Suros Surgical Systems, Inc. Education history includes an MBA from Duke University and graduate studies at Rose-Hulman Institute of Technology, Inc.
Aktive Positionen von Matthew Kane
| Unternehmen | Position | Beginn |
|---|---|---|
| CELYAD ONCOLOGY SA | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Matthew Kane
| Unternehmen | Position | Ende |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Gründer | 15.10.2021 |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. BiotechnologyHealth Technology Operates epigenome treatment medicines | Vorstandsvorsitzender | - |
Suros Surgical Systems, Inc.
Suros Surgical Systems, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Corporate Officer/Principal | - |
Ausbildung von Matthew Kane
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Suros Surgical Systems, Inc.
Suros Surgical Systems, Inc. Medical SpecialtiesHealth Technology Manufactures and develops medical devices | Health Technology |
Precision BioSciences, Inc.
Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rose-Hulman Institute of Technology, Inc.
Rose-Hulman Institute of Technology, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celyad Oncology SA
Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. BiotechnologyHealth Technology Operates epigenome treatment medicines | Health Technology |
















